Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus

INTRODUCTION: The safety and efficacy of pembrolizumab administration in patients with urothelial carcinoma and underlying autoimmune disease (including overlap syndrome) is unknown. CASE PRESENTATION: We present the case of a 67‐year‐old woman with cT3N2M0 metastatic renal pelvic cancer who had bee...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:IJU Case Rep
Egile Nagusiak: Kurokawa, Masayuki, Naito, Sei, Ito, Suguru, Takai, Satoshi, Kawamura, Yuko, Kaneko, Hisashi, Kakizaki, Hiroshi, Tsuchiya, Norihiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7469821/
https://ncbi.nlm.nih.gov/pubmed/32914068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12175
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak